XTalks
JUNE 4, 2024
In the ever-evolving landscape of pharmaceutical development, the complexity of early phase clinical trials is increasing. This surge in complexity is driven by escalating drug development costs, heightened competition and advanced scientific innovations. And that has a lot of downstream consequences.” This trend, which Dr.
pharmaphorum
DECEMBER 21, 2020
Patients in the pilot used the app developed by Sensely to self-check eligibility and quickly make appointments for flu jabs. Sensely is currently developing COVID-specific virtual tools and plans to begin supporting NHS coronavirus vaccination efforts with customised virtual assistant technologies in early 2021.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
MARCH 20, 2021
Sponsors and CROs will continue to be eager to bounce back and accelerate the drug development process after significant delays caused by the pandemic,” Reites said. . These focus areas will materialize in study designs as hybrid decentralized approaches that support global programs,” Reites said. “In Source link: [link].
Advarra
JUNE 28, 2022
As a drug successfully makes it through the development process, sponsors will inevitably need to submit a new drug application (NDA) to the Food and Drug Administration (FDA). There are a myriad of regulations coming into play during the drug development process. Developing a relationship with the agency team reviewing the submission.
Expert insights. Personalized for you.
110 
Let's personalize your content